Trials / Completed
CompletedNCT02524821
The Effect of Gelesis100 on the Pharmacokinetics of Metformin
Randomized, Open-label, 4-Way Crossover Study Assessing the Effect of Gelesis100 on the Pharmacokinetics of Metformin, Administered Under Fasting and Fed Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Gelesis, Inc. · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effect of Gelesis100 on the absorption of metformin both with and without a meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Gelesis100 | 3 capsules each containing 0.75 mg |
| DRUG | Metformin | 1 tablet of 850 mg |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-08-17
- Last updated
- 2018-06-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02524821. Inclusion in this directory is not an endorsement.